-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, F2BhP8sGTItzvxlNNkxsBm1I/BJwvWERYtzuUaLZLF/YAWiWia0wV/13mnsB2ouC QpLmruQYZv8NiMBg8XYAcQ== 0001193125-04-037068.txt : 20040309 0001193125-04-037068.hdr.sgml : 20040309 20040309131650 ACCESSION NUMBER: 0001193125-04-037068 CONFORMED SUBMISSION TYPE: DEL AM PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20040309 EFFECTIVENESS DATE: 20040309 FILER: COMPANY DATA: COMPANY CONFORMED NAME: GENOME THERAPEUTICS CORP CENTRAL INDEX KEY: 0000356830 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 042297484 STATE OF INCORPORATION: MA FISCAL YEAR END: 0831 FILING VALUES: FORM TYPE: DEL AM SEC ACT: 1933 Act SEC FILE NUMBER: 333-113359 FILM NUMBER: 04656707 BUSINESS ADDRESS: STREET 1: 1OO BEAVER ST CITY: WALTHAM STATE: MA ZIP: 02453 BUSINESS PHONE: 7813982300 MAIL ADDRESS: STREET 1: 100 BEAVER STREET CITY: WALTHAM STATE: MA ZIP: 02453 FORMER COMPANY: FORMER CONFORMED NAME: COLLABORATIVE RESEARCH INC DATE OF NAME CHANGE: 19920703 DEL AM 1 ddelam.htm DELAYING AMENDMENT DELAYING AMENDMENT

GENOME THERAPEUTICS CORP.

100 Beaver Street

Waltham, Massachusetts 02453

 

                        March 9, 2004

 

U.S. Securities and Exchange Commission

450 Fifth Street, N.W.

Washington, DC 20549

 

  Re:   Genome Therapeutics Corp.
         Registration Statement on Form S-3
         (File No: 333- 113359)

 

Ladies and Gentlemen:

 

Reference is made to the registration statement on Form S-3 filed by Genome Therapeutics Corp. (the “Registrant”) on March 5, 2004 with Registration Number 333-113359 (the “Registration Statement”). Please be advised that the Registrant hereby amends the facing page of the Registration Statement to state, in accordance with Section 8(a) of the Securities Act, as amended, and Rule 473 thereunder, that:

 

The registrant hereby amends this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file a further amendment which specifically states that this registration statement shall thereafter become effective in accordance with Section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such date as the Commission, acting pursuant to said Section 8(a), may determine.

 

If you have any questions with respect to the above, please do not hesitate contact the undersigned at (781) 398-2300.

 

 

Very truly yours,

 

GENOME THERAPEUTICS CORP.

/s/    STEPHEN COHEN

Name:    Stephen Cohen

Title:      Senior Vice President and Chief Financial Officer

 -----END PRIVACY-ENHANCED MESSAGE-----